A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
Malcolm H SquiresCecilia G EthunErin E DonahueJennifer H BenbowColin J AndersonMegan H JagoskyJonathan C SaloJoshua S HillWilliam AhrensRoshan S PrabhuMichael B LivingstonNicole L GowerMckenzie NeedhamSally J TrufanRyan C FieldsBradley Aaron KrasnickMeena BediDaniel E AbbottPatrick B SchwartzKonstantinos VotanopoulosKonstantinos ChouliarasValerie GrignolKevin K RogginJennifer TsengGeorge PoultsidesThuy B TranKenneth CardonaJ Harrison HowardPublished in: Journal of surgical oncology (2021)
In a diverse, modern validation cohort of patients with resected primary RPS, both Sarculator and MSK nomograms demonstrated good prognostic ability, supporting their ongoing adoption into clinical practice.